Legend Biotech Corp - ADR
LEGN
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.02B
Close$
Share Statistics
| Market cap | $5.02 Billion |
|---|---|
| Enterprise Value | $4.77 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.6 |
| Beta | 0.3 |
| Outstanding Shares | 184,733,092 |
Return
| Return on Equity | -25.94% |
|---|---|
| Return on Assets | -15.72% |
| Return on Invested Capital | -20.25% |
Valuation & Multiples
| P/E Ratio | -20.05 |
|---|---|
| PEG | 43.57 |
| Price to Sales | 6.0 |
| Price to Book Ratio | 7.2 |
| Enterprise Value to Revenue | 4.18 |
| Enterprise Value to EBIT | -21.67 |
| Enterprise Value to Net Income | -20 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.41 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
$0.03
Average shareholder expectationRevenue Estimate
$321.82 M
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$0.05
Average shareholder expectationRevenue Estimate
$360.46 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7221▼ 23.48% |
|---|---|
| Total Calls | 569,200▲ 5.43% |
| Total Puts | 411,000▼ 20.44% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 51.66%▼ 45.46% |
|---|---|
| Total Invested | $1.73B▼ 9.53% |
| Investors Holding | 207▼ 9.00% |
ESG Score
No data